Literature DB >> 19470577

The FDA as a public health agency.

Margaret A Hamburg1, Joshua M Sharfstein.   

Abstract

Mesh：

Year:  2009        PMID： 19470577     DOI： 10.1056/NEJMp0903764

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

1.  The communication challenges presented by nanofoods.

Authors:  Timothy V Duncan
Journal:  Nat Nanotechnol       Date:  2011-10-30       Impact factor: 39.213

2.  A Major Shortcoming in the Public Health Legacy of the Obama Administration.

Authors:  Diana M Zuckerman
Journal:  Am J Public Health       Date:  2017-01       Impact factor: 9.308

Review 3.  Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review.

Authors:  Stacie B Dusetzina; Ashley S Higashi; E Ray Dorsey; Rena Conti; Haiden A Huskamp; Shu Zhu; Craig F Garfield; G Caleb Alexander
Journal:  Med Care       Date:  2012-06       Impact factor: 2.983

4.  Personalizing medicine for cancer: the next decade.

Authors:  Ernest C Borden; Derek Raghavan
Journal:  Nat Rev Drug Discov       Date:  2010-05       Impact factor: 84.694

Review 5.  Pharmaceutical Benefit-Risk Communication Tools: A Review of the Literature.

Authors:  Dominic Way; Hortense Blazsin; Ragnar Löfstedt; Frederic Bouder
Journal:  Drug Saf       Date:  2017-01       Impact factor: 5.606

6.  Innovation under Regulatory Uncertainty: Evidence from Medical Technology.

Authors:  Ariel Dora Stern
Journal:  J Public Econ       Date:  2016-11-23

7.  Beliefs about FDA tobacco regulation, modifiability of cancer risk, and tobacco product comparative harm perceptions: Findings from the HINTS-FDA 2015.

Authors:  Anh B Nguyen; James Henrie; Wendy I Slavit; Annette R Kaufman
Journal:  Prev Med       Date:  2018-01-31       Impact factor: 4.018

8.  Ethical and Practical Considerations in Removing Black Box Warnings from Drug Labels.

Authors:  James S Yeh; Ameet Sarpatwari; Aaron S Kesselheim
Journal:  Drug Saf       Date:  2016-08       Impact factor: 5.606

9.  Consumer Understanding, Preferences, and Responses to Different Versions of Drug Safety Messages in the United States: A Randomized Controlled Trial.

Authors:  Lauren McCormack; R Craig Lefebvre; Carla Bann; Olivia Taylor; Paula Rausch
Journal:  Drug Saf       Date:  2016-02       Impact factor: 5.606

10.  Adaptive Biomedical Innovation: Evolving Our Global System to Sustainably and Safely Bring New Medicines to Patients in Need.

Authors:  G Hirsch; M Trusheim; E Cobbs; M Bala; S Garner; D Hartman; K Isaacs; M Lumpkin; R Lim; K Oye; E Pezalla; P Saltonstall; H Selker
Journal:  Clin Pharmacol Ther       Date:  2016-10-22       Impact factor: 6.875
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.